Suppr超能文献

大黄素,一种天然存在的蒽醌,通过激活线粒体钙单向转运蛋白,成为一种高效的肥大细胞稳定剂。

Aloe-emodin, a naturally occurring anthraquinone, is a highly potent mast cell stabilizer through activating mitochondrial calcium uniporter.

机构信息

Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100193, China.

Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China.

出版信息

Biochem Pharmacol. 2021 Apr;186:114476. doi: 10.1016/j.bcp.2021.114476. Epub 2021 Feb 17.

Abstract

Mast cells play a fundamental role in immune system. Upon stimulation, they are activated via IgE dependent or independent pathway and then release granules which contain plenty of preformed constituents. Mast cell stabilizers are commonly used clinically for inhibiting the degranulation of mast cells. In the current study, we firstly identified aloe-emodin, a naturally occurring anthraquinone, was a prominent mast cell stabilizer. It could strikingly dampen IgE/FcεRI- and MAS-related G protein coupled receptor (Mrgpr)-mediated mast cell degranulation in vitro and in vivo. Mechanism study indicated that aloe-emodin rapidly and reversibly decreased cytosolic Ca (Ca) concentration through enhancing the mitochondrial Ca (Ca) uptake. After genetically silencing or pharmacologic inhibiting mitochondrial calcium uniporter (MCU), the effects of aloe-emodin on the Ca level and mast cell degranulation were significantly weakened. In contrast to six clinical drugs with mast cell stabilizing properties (amlexanox, tranilast, ketotifen, cromolyn disodium salt, dexamethasone and pimecrolimus), aloe-emodin showed an impressive and potent inhibitory action on the mast cell degranulation. Collectively, aloe-emodin is a highly potent mast cell stabilizer. By directly activating MCU, it decreases Ca level to suppress mast cell degranulation. Our study may provide a promising candidate for the treatment of mast cell activation-related diseases.

摘要

肥大细胞在免疫系统中发挥着重要作用。在受到刺激时,它们通过 IgE 依赖性或非依赖性途径被激活,然后释放含有大量预先形成成分的颗粒。肥大细胞稳定剂常用于临床抑制肥大细胞脱颗粒。在本研究中,我们首次鉴定出大黄素,一种天然存在的蒽醌,是一种显著的肥大细胞稳定剂。它可以显著抑制体外和体内 IgE/FcεRI 和 MAS 相关 G 蛋白偶联受体(Mrgpr)介导的肥大细胞脱颗粒。机制研究表明,大黄素通过增强线粒体钙摄取,迅速而可逆地降低细胞质 Ca(Ca)浓度。在基因沉默或药理学抑制线粒体钙单向转运蛋白(MCU)后,大黄素对 Ca 水平和肥大细胞脱颗粒的作用明显减弱。与具有肥大细胞稳定特性的六种临床药物(氨来呫诺、曲尼司特、酮替芬、色甘酸钠、地塞米松和吡美莫司)相比,大黄素对肥大细胞脱颗粒具有显著而有效的抑制作用。总之,大黄素是一种高效的肥大细胞稳定剂。通过直接激活 MCU,降低 Ca 水平抑制肥大细胞脱颗粒。我们的研究可能为治疗肥大细胞激活相关疾病提供了一种有前途的候选药物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验